MADISON, Wis., Jan.13, 2017
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced
that, in support of the Company's continued growth plans, it
granted restricted stock units covering a total of 53,275 shares of
common stock to 45 recently hired non-executive employees under its
previously announced inducement grant program. The restricted stock
unit awards vest in four equal annual installments beginning on the
first anniversary of the grant date. The awards were granted
as an inducement material to the recently hired employees entering
into employment with the Company in accordance with NASDAQ
Marketplace Rule 5635(c)(4). The Company is making this
announcement as required by NASDAQ rules.
About Exact Sciences Corp.
Exact Sciences Corp. is a molecular diagnostics company focused
on the early detection and prevention of the deadliest forms of
cancer. The company has exclusive intellectual property protecting
its non-invasive, molecular screening technology for the detection
of colorectal cancer. For more information, please visit the
company's website at www.exactsciences.com, follow Exact
Sciences on Twitter @ExactSciences or find Exact Sciences on
Facebook.
This news release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended,
that are intended to be covered by the "safe harbor" created by
those sections. Forward-looking statements, which are based on
certain assumptions and describe our future plans, strategies and
expectations, can generally be identified by the use of
forward-looking terms such as "believe," "expect," "may," "will,"
"should," "could," "seek," "intend," "plan," "estimate,"
"anticipate" or other comparable terms. All statements other than
statements of historical facts included in this news release
regarding our strategies, prospects, financial condition,
operations, costs, plans and objectives are forward-looking
statements. Examples of forward-looking statements include, among
others, statements we make regarding expected future operating
results, anticipated results of our sales and marketing efforts,
expectations concerning payor reimbursement and the anticipated
results of our product development efforts. Forward-looking
statements are neither historical facts nor assurances of future
performance. Instead, they are based only on our current beliefs,
expectations and assumptions regarding the future of our business,
future plans and strategies, projections, anticipated events and
trends, the economy and other future conditions. Because
forward-looking statements relate to the future, they are subject
to inherent uncertainties, risks and changes in circumstances that
are difficult to predict and many of which are outside of our
control. Our actual results and financial condition may differ
materially from those indicated in the forward-looking statements.
Therefore, you should not rely on any of these forward-looking
statements. Important factors that could cause our actual results
and financial condition to differ materially from those indicated
in the forward-looking statements include, among others, the
following: our ability to successfully and profitably market our
products and services; the acceptance of our products and services
by patients and healthcare providers; the willingness of health
insurance companies and other payors to cover Cologuard® and
reimburse us for our performance of the Cologuard test; the amount
and nature of competition from other cancer screening products and
services; the effects of any healthcare reforms, including the
Affordable Care Act, or changes in healthcare pricing, coverage and
reimbursement; recommendations, guidelines and quality metrics
issued by various organizations such as the U.S. Preventive
Services Task Force , the American Cancer Society, and the National
Committee for Quality Assurance regarding cancer screening or our
products and services; our ability to successfully develop new
products and services; our success establishing and maintaining
collaborative, licensing and supplier arrangements; our ability to
maintain regulatory approvals and comply with applicable
regulations; and the other risks and uncertainties described in the
Risk Factors and in Management's Discussion and Analysis of
Financial Condition and Results of Operations sections of our most
recently filed Annual Report on Form 10-K and our subsequently
filed Quarterly Report(s) on Form 10-Q. We undertake no obligation
to publicly update any forward-looking statement, whether written
or oral, that may be made from time to time, whether as a result of
new information, future developments or otherwise.
Contact:
J.P. Fielder
Senior Director, Corporate Communications, Exact Sciences Corp.
608-210-5220
jpfielder@exactsciences.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/exact-sciences-grants-inducement-restricted-stock-unit-awards-to-recently-hired-employees-300390972.html
SOURCE EXACT SCIENCES CORP